나프록센 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "나프록센" in Korean language version.

refsWebsite

Global rank Korean rank

2^nd place

3^rd place

4^th place

4^th place

low place

low place

3,258^th place

1,025^th place

399^th place

141^st place

838^th place

317^th place

1web.archive.org

1^st place

1^st place

low place

6,459^th place

3,912^th place

2,490^th place

low place

low place

clincalc.com

“The Top 300 of 2019”. 《clincalc.com》. 2018년 12월 22일에 확인함.

comlaw.gov.au

Gill, A, 편집. (July 2013). 《Standard for the Uniform Scheduling of Medicines and Poisons No. 4》 (PDF). 《The Poisons Standard 2013》 (Therapeutic Goods Administration). ISBN 978-1-74241-895-7.

doi.org

dx.doi.org

Angiolillo DJ, Weisman SM (April 2017). “Clinical Pharmacology and Cardiovascular Safety of Naproxen”. 《American Journal of Cardiovascular Drugs》 17 (2): 97–107. doi:10.1007/s40256-016-0200-5. PMID 27826802.
Harrington PJ, Lodewijk E (1997). “Twenty Years of Naproxen Technology”. 《en:Org. Process Res. Dev.》 1 (1): 72–76. doi:10.1021/op960009e.

drugs.com

“Naproxen Monograph for Professionals”. 《Drugs.com》 (영어). AHFS. 2018년 12월 19일에 확인함.

google.ca

books.google.ca

McEvoy, Gerald K. (2000). 《AHFS Drug Information, 2000》 (영어). American Society of Health-System Pharmacists. 1854쪽. ISBN 9781585280049.

medicaid.gov

data.medicaid.gov

“NADAC as of 2018-12-19”. 《Centers for Medicare and Medicaid Services》 (영어). 2018년 12월 19일에 원본 문서에서 보존된 문서. 2018년 12월 22일에 확인함.

nice.org.uk

bnf.nice.org.uk

“NAPROXEN”. 《British National Formulary》.

nih.gov

ncbi.nlm.nih.gov

Angiolillo DJ, Weisman SM (April 2017). “Clinical Pharmacology and Cardiovascular Safety of Naproxen”. 《American Journal of Cardiovascular Drugs》 17 (2): 97–107. doi:10.1007/s40256-016-0200-5. PMID 27826802.

web.archive.org

“NADAC as of 2018-12-19”. 《Centers for Medicare and Medicaid Services》 (영어). 2018년 12월 19일에 원본 문서에서 보존된 문서. 2018년 12월 22일에 확인함.

wikipedia.org

en.wikipedia.org

Harrington PJ, Lodewijk E (1997). “Twenty Years of Naproxen Technology”. 《en:Org. Process Res. Dev.》 1 (1): 72–76. doi:10.1021/op960009e.